Archive: 12/03/2012
Clinical trial targets advanced prostate cancer
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
Cancer
Dec 03, 2012 |
5 / 5 (1) |
0
New research opens new pathway for the treatment of Alzheimer's disease
Scientists from VIB and KU Leuven have discovered a new target molecule for the development of a treatment against Alzheimer's disease. There is currently no cure for this disease. Many candidate drugs fail because they also ...
Alzheimer's disease & dementia
Dec 03, 2012 |
not rated yet |
0
Experts urge rapid evaluation for swallowing and voice problems after brain surgery
Johns Hopkins experts are recommending early post-surgical assessment—preferably within 24 hours—for trouble chewing and swallowing food, or speaking normally, among patients who have had benign tumors removed from the ...
Cancer
Dec 03, 2012 |
not rated yet |
0
Lithium restores cognitive function in Down syndrome mice
Down syndrome is a neurodevelopmental disorder that is the leading cause of genetically defined intellectual disability. In the brain, Down syndrome results in alterations in the connections between neurons and a reduction ...
Neuroscience
Dec 03, 2012 |
5 / 5 (3) |
1
Stem cell-derived dopaminergic neurons rescue motor defects in Parkinsonian monkeys
Parkinson's disease is a degenerative disorder of the central nervous system that is characterized by tremors, rigidity, slowness of movement, and difficulty walking. It is caused by loss of the neurons that produce the neurotransmitter ...
Parkinson's & Movement disorders
Dec 03, 2012 |
5 / 5 (1) |
0
Rules limiting aggression should reduce hockey injuries
Mandatory rules such as restricting body checking can limit aggression and reduce injuries in ice hockey, making the game safer for young people, a new study has found.
Health
Dec 03, 2012 |
not rated yet |
0
Risk of blood clots two-fold for women with polycystic ovary syndrome on combined pill
Women with polycystic ovary syndrome (PCOS) who are taking combined oral contraceptives have a 2-fold risk of blood clots compared with women without the disorder who take contraceptives, states a study published in CMAJ (Canad ...
Medications
Dec 03, 2012 |
not rated yet |
0
Clinical trial hits new target in war on breast cancer
Breast cancers are defined by their drivers – estrogen and progesterone receptors (ER and PR) and HER2 are the most common, and there are drugs targeting each. When breast cancer has an unknown driver, it also has fewer ...
Cancer
Dec 03, 2012 |
5 / 5 (2) |
0
|
Research explores markers of depression from childhood to adulthood
Although several studies have followed the course of depression throughout the lifespan, the characteristics of depression at different developmental stages haven't been clearly identified. New research published in Clinical Psych ...
Psychology & Psychiatry
Dec 03, 2012 |
not rated yet |
0
|
Study describes 68 CTE cases in veterans, high school, college and pro athletes
A study done by investigators at the Boston University Center for the Study of Traumatic Encephalopathy (CSTE) and the Veterans Affairs Boston Healthcare System, in collaboration with the Sports Legacy Institute (SLI), describes ...
Diseases, Conditions, Syndromes
Dec 03, 2012 |
not rated yet |
0
FDA pledges support for med tech initiative
(AP)—The Food and Drug Administration says it will collaborate with medical device manufacturers on a public-private partnership designed to speed up the development of new medical technology.
Medications
Dec 03, 2012 |
not rated yet |
0
Cabozantinib active in castration-resistant prostate cancer
(HealthDay)—The orally bioavailable tyrosine kinase inhibitor cabozantinib (XL184) has clinical activity in men with castration-resistant prostate cancer (CRPC), according to a study published online Nov. ...
Cancer
Dec 03, 2012 |
not rated yet |
0
Managing erectile dysfunction, comorbid diseases linked
(HealthDay)—Diagnosis and management of erectile dysfunction (ED) improves health outcomes for men with comorbid diseases, and vice versa, according to research published online Nov. 15 in The Journal of ...
Diseases, Conditions, Syndromes
Dec 03, 2012 |
not rated yet |
0
'Junk DNA' drives embryonic development
An embryo is an amazing thing. From just one initial cell, an entire living, breathing body emerges, full of working cells and organs. It comes as no surprise that embryonic development is a very carefully ...
Genetics
Dec 03, 2012 |
5 / 5 (9) |
21
|
Largest coronary artery disease study shows evidence of link between inflammation and heart disease
The University of Ottawa Heart Institute (UOHI) participated in the largest genetic study of Coronary Artery Disease (CAD) to date. Researchers from the CARDIoGRAMplusC4D Consortium report the identification of 15 genetic ...
Genetics
Dec 03, 2012 |
3.5 / 5 (2) |
0
|
